3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
2
Genitourinary
2
Dermatologic
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Breast
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia, Lymphocytic, Chronic, B-Cell
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Preleukemia
2
Precancerous Conditions
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Multiple Chronic Conditions
2
Lymphoproliferative Disorders
2
Lymphoma
2
Lymphatic Diseases
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Bone Marrow Diseases
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Interventions
fludarabine phosphate
4
Cyclophosphamide
4
Antilymphocyte Serum
4
Mycophenolic Acid
3
Filgrastim
3
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Cyclosporine
2
Busulfan
2
thymoglobulin
1
sargramostim
1
ixabepilone
1
fludarabine
1
cc-486
1
aldesleukin
1
Whole-Body Irradiation
1
Voriconazole
1
Stem Cell Transplantation
1
Radiotherapy
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Interleukin-12 Subunit p35
1
Interferon-alpha
1
Injections
1
Immunotherapy
1
Granulocyte Colony-Stimulating Factor
1
Drug Therapy
1
Cord Blood Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Patient Reported Outcome Measures
×
Myeloid
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled